Literature DB >> 26658914

Autophagy inhibitors.

Benoit Pasquier1.   

Abstract

Autophagy is a lysosome-dependent mechanism of intracellular degradation. The cellular and molecular mechanisms underlying this process are highly complex and involve multiple proteins, including the kinases ULK1 and Vps34. The main function of autophagy is the maintenance of cell survival when modifications occur in the cellular environment. During the past decade, extensive studies have greatly improved our knowledge and autophagy has exploded as a research field. This process is now widely implicated in pathophysiological processes such as cancer, metabolic, and neurodegenerative disorders, making it an attractive target for drug discovery. In this review, we will summarize the different types of inhibitors that affect the autophagy machinery and provide some potential therapeutic perspectives.

Entities:  

Keywords:  Autophagosomes; Autophagy; Hydroxychloroquine; Lysosomotropic agent; PI3K; PIK3C3/Vps34; ULK

Mesh:

Substances:

Year:  2015        PMID: 26658914     DOI: 10.1007/s00018-015-2104-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  131 in total

Review 1.  Cell death by autophagy: facts and apparent artefacts.

Authors:  D Denton; S Nicolson; S Kumar
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

Review 2.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 3.  A current perspective of autophagosome biogenesis.

Authors:  Shusaku T Shibutani; Tamotsu Yoshimori
Journal:  Cell Res       Date:  2013-12-03       Impact factor: 25.617

4.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.

Authors:  Baptiste Ronan; Odile Flamand; Lionel Vescovi; Christine Dureuil; Laurence Durand; Florence Fassy; Marie-France Bachelot; Annabelle Lamberton; Magali Mathieu; Thomas Bertrand; Jean-Pierre Marquette; Youssef El-Ahmad; Bruno Filoche-Romme; Laurent Schio; Carlos Garcia-Echeverria; Hélène Goulaouic; Benoit Pasquier
Journal:  Nat Chem Biol       Date:  2014-10-19       Impact factor: 15.040

Review 5.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

6.  Unc-51-like kinase 1/2-mediated endocytic processes regulate filopodia extension and branching of sensory axons.

Authors:  Xiang Zhou; J Ramesh Babu; Susana da Silva; Qing Shu; Isabella A Graef; Tim Oliver; Toshifumi Tomoda; Tomomi Tani; Marie W Wooten; Fan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

7.  3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism.

Authors:  L H Caro; P J Plomp; E J Wolvetang; C Kerkhof; A J Meijer
Journal:  Eur J Biochem       Date:  1988-08-01

8.  Analysis of a lung defect in autophagy-deficient mouse strains.

Authors:  Heesun Cheong; Junmin Wu; Linda K Gonzales; Susan H Guttentag; Craig B Thompson; Tullia Lindsten
Journal:  Autophagy       Date:  2013-11-11       Impact factor: 16.016

9.  A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling.

Authors:  Zachary A Knight; Beatriz Gonzalez; Morri E Feldman; Eli R Zunder; David D Goldenberg; Olusegun Williams; Robbie Loewith; David Stokoe; Andras Balla; Balazs Toth; Tamas Balla; William A Weiss; Roger L Williams; Kevan M Shokat
Journal:  Cell       Date:  2006-04-27       Impact factor: 41.582

10.  FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells.

Authors:  Taichi Hara; Akito Takamura; Chieko Kishi; Shun-Ichiro Iemura; Tohru Natsume; Jun-Lin Guan; Noboru Mizushima
Journal:  J Cell Biol       Date:  2008-04-28       Impact factor: 10.539

View more
  81 in total

1.  FANCD2 protects against bone marrow injury from ferroptosis.

Authors:  Xinxin Song; Yangchun Xie; Rui Kang; Wen Hou; Xiaofang Sun; Michael W Epperly; Joel S Greenberger; Daolin Tang
Journal:  Biochem Biophys Res Commun       Date:  2016-10-20       Impact factor: 3.575

Review 2.  Relevance of autophagy to fatty liver diseases and potential therapeutic applications.

Authors:  Shengmin Yan; Nazmul Huda; Bilon Khambu; Xiao-Ming Yin
Journal:  Amino Acids       Date:  2017-05-06       Impact factor: 3.520

3.  Targeting the Autophagy Specific Lipid Kinase VPS34 for Cancer Treatment: An Integrative Repurposing Strategy.

Authors:  Poornimaa Murali; Kanika Verma; Thanyada Rungrotmongkol; Perarasu Thangavelu; Ramanathan Karuppasamy
Journal:  Protein J       Date:  2021-01-05       Impact factor: 2.371

Review 4.  Autophagy-dependent secretion: mechanism, factors secreted, and disease implications.

Authors:  Jacob New; Sufi Mary Thomas
Journal:  Autophagy       Date:  2019-04-14       Impact factor: 16.016

Review 5.  Targeting autophagy in cancer.

Authors:  Jean M Mulcahy Levy; Christina G Towers; Andrew Thorburn
Journal:  Nat Rev Cancer       Date:  2017-07-28       Impact factor: 60.716

6.  TRIM37 deficiency induces autophagy through deregulating the MTORC1-TFEB axis.

Authors:  Wei Wang; Zhijie Xia; Jean-Claude Farré; Suresh Subramani
Journal:  Autophagy       Date:  2018-08-21       Impact factor: 16.016

7.  Stapled Peptide Inhibitors of Autophagy Adapter LC3B.

Authors:  Robert A Cerulli; Livia Shehaj; Hawley Brown; Jennifer Pace; Yang Mei; Joshua A Kritzer
Journal:  Chembiochem       Date:  2020-06-22       Impact factor: 3.164

8.  Lgl reduces endosomal vesicle acidification and Notch signaling by promoting the interaction between Vap33 and the V-ATPase complex.

Authors:  Marta Portela; Liu Yang; Sayantanee Paul; Xia Li; Alexey Veraksa; Linda M Parsons; Helena E Richardson
Journal:  Sci Signal       Date:  2018-06-05       Impact factor: 8.192

Review 9.  A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.

Authors:  Priyanka Dash; Subhashree Mohapatra; Sayantan Ghosh; Bismita Nayak
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

10.  ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).

Authors:  Gisela Weskamp; Johanna Tüshaus; Daniel Li; Regina Feederle; Thorsten Maretzky; Steven Swendemann; Erik Falck-Pedersen; David R McIlwain; Tak W Mak; Jane E Salmon; Stefan F Lichtenthaler; Carl P Blobel
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.